Ropivacaine (mixed presentations): Hospital supply issue
This issue affects five presentations of Ropivacaine Kabi.
28 August 2025 | Update
Supply remains constrained. The supplier is arranging some air freight supplies to support the issue. Large sea shipments are expected to arrive in September.
Affected product
Because of constraints in the manufacturing plant, Fresenius Kabi has low or very low supplies of some ropivacaine presentations. Although shipments of some presentations have arrived, supply continues to be constrained. The most affected products are as follows.
| Presentation | Pharmacode | Supply status | Next shipment |
|---|---|---|---|
| 2 mg/ml, 20 ml ampoule | 2478714 | Limited (on allocation) | Stock has arrived |
| 2 mg/ml, 100 ml bag | 2479125 | Available | To be advised |
| 7.5 mg/ml, 10 ml ampoule | 2478722 | Out of stock | Stock has arrived |
| 7.5 mg/ml, 20 ml ampoule | 2478730 | Limited (on allocation) | Stock has arrived |
| 10 mg/ml, 10 ml amp | 2478749 | Out of stock | late August 2025 |
Other presentations remain available.
Ropivacaine listings in the HML(external link)
Shipments
The dates given in the table are for when stock arrives in New Zealand. The product will still need to clear standard quality control processes before being released. Fresenius Kabi is working to make that process as quick as possible.
The next shipments listed will not resolve the issue completely. We are continuing to monitor the situation and will keep this page up to date.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)